Logo image of ATPC

AGAPE ATP CORP (ATPC) Stock Fundamental Analysis

NASDAQ:ATPC - Nasdaq - US0083892077 - Common Stock - Currency: USD

1.87  +0.28 (+17.61%)

After market: 1.98 +0.11 (+5.88%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ATPC. ATPC was compared to 106 industry peers in the Health Care Providers & Services industry. The financial health of ATPC is average, but there are quite some concerns on its profitability. ATPC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ATPC had negative earnings in the past year.
In the past year ATPC has reported a negative cash flow from operations.
In the past 5 years ATPC reported 4 times negative net income.
In the past 5 years ATPC always reported negative operating cash flow.
ATPC Yearly Net Income VS EBIT VS OCF VS FCFATPC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M

1.2 Ratios

With a Return On Assets value of -76.25%, ATPC is not doing good in the industry: 92.45% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -127.81%, ATPC is doing worse than 79.25% of the companies in the same industry.
Industry RankSector Rank
ROA -76.25%
ROE -127.81%
ROIC N/A
ROA(3y)-57.8%
ROA(5y)-44.39%
ROE(3y)-95.22%
ROE(5y)-71.18%
ROIC(3y)N/A
ROIC(5y)N/A
ATPC Yearly ROA, ROE, ROICATPC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

1.3 Margins

With a decent Gross Margin value of 57.40%, ATPC is doing good in the industry, outperforming 78.30% of the companies in the same industry.
ATPC's Gross Margin has improved in the last couple of years.
ATPC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.67%
GM growth 5Y51.9%
ATPC Yearly Profit, Operating, Gross MarginsATPC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

6

2. Health

2.1 Basic Checks

ATPC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ATPC has been increased compared to 1 year ago.
The number of shares outstanding for ATPC has been reduced compared to 5 years ago.
The debt/assets ratio for ATPC is higher compared to a year ago.
ATPC Yearly Shares OutstandingATPC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ATPC Yearly Total Debt VS Total AssetsATPC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

ATPC has an Altman-Z score of 37.22. This indicates that ATPC is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 37.22, ATPC belongs to the best of the industry, outperforming 99.06% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that ATPC is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.06, ATPC is doing good in the industry, outperforming 77.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 37.22
ROIC/WACCN/A
WACC8.97%
ATPC Yearly LT Debt VS Equity VS FCFATPC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

A Current Ratio of 2.48 indicates that ATPC has no problem at all paying its short term obligations.
ATPC has a better Current ratio (2.48) than 79.25% of its industry peers.
A Quick Ratio of 2.44 indicates that ATPC has no problem at all paying its short term obligations.
ATPC's Quick ratio of 2.44 is fine compared to the rest of the industry. ATPC outperforms 79.25% of its industry peers.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 2.44
ATPC Yearly Current Assets VS Current LiabilitesATPC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ATPC have decreased strongly by -140.43% in the last year.
The Revenue has decreased by -7.57% in the past year.
Measured over the past years, ATPC shows a decrease in Revenue. The Revenue has been decreasing by -3.12% on average per year.
EPS 1Y (TTM)-140.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.05%
Revenue 1Y (TTM)-7.57%
Revenue growth 3Y9.05%
Revenue growth 5Y-3.12%
Sales Q2Q%-7.95%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ATPC Yearly Revenue VS EstimatesATPC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ATPC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATPC Price Earnings VS Forward Price EarningsATPC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATPC Per share dataATPC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ATPC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AGAPE ATP CORP

NASDAQ:ATPC (4/17/2025, 8:02:52 PM)

After market: 1.98 +0.11 (+5.88%)

1.87

+0.28 (+17.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-31 2025-03-31
Earnings (Next)05-12 2025-05-12
Inst Owners1.8%
Inst Owner Change0%
Ins Owners24.57%
Ins Owner ChangeN/A
Market Cap93.52M
AnalystsN/A
Price TargetN/A
Short Float %7.49%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 70.7
P/FCF N/A
P/OCF N/A
P/B 48.38
P/tB 48.71
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.03
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -76.25%
ROE -127.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.4%
FCFM N/A
ROA(3y)-57.8%
ROA(5y)-44.39%
ROE(3y)-95.22%
ROE(5y)-71.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.67%
GM growth 5Y51.9%
F-Score1
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 87.61%
Cap/Sales 3.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.48
Quick Ratio 2.44
Altman-Z 37.22
F-Score1
WACC8.97%
ROIC/WACCN/A
Cap/Depr(3y)66.43%
Cap/Depr(5y)39.86%
Cap/Sales(3y)3.02%
Cap/Sales(5y)1.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-140.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.57%
Revenue growth 3Y9.05%
Revenue growth 5Y-3.12%
Sales Q2Q%-7.95%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-35.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.19%
OCF growth 3YN/A
OCF growth 5YN/A